The Shanghai-based medtech business has received RMB 400million (£46.9million) in Series D funding, led by SoftBank Vision Fund 2 and backed by existing investor Saudi Aramco P7 Venture Fund, alongside Yuanjing Vision Plus Capital.
The latest funding – which comes shortly after Fourier became the first rehab robotics business to attract a major investor on board through its partnership with Saudi Aramco – will accelerate Fourier’s go-to-market expansion for its array of rehab devices, enable innovation across its advanced healthcare robotics solutions and accelerate global growth opportunities.
Leveraging on intelligent robotics, smart actuators, sensors, machine learning, and proprietary control algorithms, Fourier develops and provides an intelligent healthcare robotic platform, RehabHub™, that delivers tailored digital healthcare solutions that revolutionise the neurorehabilitation industry.
Driven by its vision of ‘rehabilitation for all’ through intelligent technology, Fourier Intelligence implemented a series of modern rehabilitationcentres with strategic institutional clinical partners under its RehabHub™ concept.
The possibility of data interconnectivity and multi-machine coordination between multiple rehabilitation robotics reduced the number of clinicians required, significantly improving efficiency and costs.
The company aims to become a global one-stop solution provider provider for intelligent rehabilitation whilst providing world-class technology that is affordable and highly competitive for the clinical market.